Salarius Pharmaceuticals, Inc. — Form D
Salarius Pharmaceuticals, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-05. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-05-05
- Form: D
- Accession: 0001567619-22-009611
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $2.3M
- Investors: 4
- Date of first sale: 2022-04-25
- Revenue range: Decline to Disclose
- SEC file number: 021-444688
Issuer
- Name: Salarius Pharmaceuticals, Inc.
- CIK: 0001615219
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2540 Holcombe Blvd., Houston, TX, 77021
- Phone: 832-834-9144
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Tess K Burleson | Director | Houston, TX |
| Christoph Westphal | Director | CAMBRIDGE, MA |
| Christoph Westphal | Executive Officer | CAMBRIDGE, MA |
| Arnold C Hanish | Director | Houston, TX |
| Jonathan J Lieber | Director | Houston, TX |
| Mark J Rosenblum | Executive Officer | Houston, TX |
| William J McVicar | Director | Houston, TX |
| Bruce J McCreedy | Director | Houston, TX |
| Paul C Lammers | Director | Houston, TX |
| Tess J Burleson | Director | Houston, TX |
| David J Arthur | Director | Canton, MA |
| David J Arthur | Executive Officer | Canton, MA |
| Peter Barton Hutt | Director | Salt Lake City, UT |
| William K McVicar | Director | Houston, TX |
| Tess Burleson | Director | Houston, TX |
| Jonathan C Lieber | Director | Houston, TX |
| Stephen Barton Kraus | Director | Boston, MA |
Other filings by this issuer (3)
More